Tag: therapeutics

Creativity Hubs Award Funds New Implant Device To Revolutionize Chronic Disease Management

CREATIVITY HUBS AWARD FAST-TRACKS DEVELOPMENT OF IMPLANTABLE TECHNOLOGIES THAT COULD DISRUPT HEALTHCARE IN NORTH CAROLINA, NATIONWIDE, AND GLOBALLY     A new implantable device termed Autonomous Living Therapies for Extended Results (ALTER) could change the way chronic diseases are managed by offering a promising solution to one of the biggest challenges in healthcare: poor medication… Continue reading Creativity Hubs Award Funds New Implant Device To Revolutionize Chronic Disease Management

WRAL Visits Freeman Lab to Explore Potential Alzheimer’s Cure

WRAL Visits Freeman Lab to Explore Potential Alzheimer’s Cure WRAL’s Grace Hayba visited the Freeman Lab to sit down with Professor Ronit Freeman to learn about the new discovery in a way to potentially reverse the twist direction of amyloid plaques in the brain which are instrumental in neurodegenerative disorders such as Alzheimer’s disease.   … Continue reading WRAL Visits Freeman Lab to Explore Potential Alzheimer’s Cure

Interview with the Women of the Freeman Lab

Breaking Barriers in Science: An Interview with the Women of the Freeman Lab Breaking Barriers in Science: An Interview with the Women of the Freeman Lab Freeman Lab scientists with Justin Hill  March 8, 2024 In a wing of the UNC-Chapel Hill campus, spanning the Kenan, Caudill and Murray buildings; you will find the Freeman… Continue reading Interview with the Women of the Freeman Lab

Article: A Twist on Traditional Treatment

Imagine a future where the insidious advance of Alzheimer’s could be halted, or even reversed, not by a miraculous new drug, but by a groundbreaking way of delivering treatment right to the heart of the problem. This isn’t the plot of a science fiction novel but the tangible outcome of cutting-edge research by a team… Continue reading Article: A Twist on Traditional Treatment

Targeted therapy treatments – with a twist!

Twisted Ribbons

UNC-Chapel Hill researchers have developed a therapeutic approach that harnesses helical amyloid fibers designed to untwist and release drugs in response to body temperature, according to a study published in Nature Communications. “Understanding the structural and assembly properties of the beta-amyloid 42 peptide is crucial for advancing our knowledge of Alzheimer’s and developing targeted therapies for… Continue reading Targeted therapy treatments – with a twist!

Freeman Lab receives Harrington Scholar award for game-changing pulmonary fibrosis drug discovery

In collaboration with James Hagood, Ronit Freeman has received funding for new drug discovery for the treatment of pulmonary fibrosis (PF). Currently, PF has no breakthrough treatment, and has an annual mortality on par with breast cancer in the US. This new funding is poised to help reverse the lung damage caused by PF. Read… Continue reading Freeman Lab receives Harrington Scholar award for game-changing pulmonary fibrosis drug discovery

new appointment: Ronit Freeman to Serve as Associate Editor of Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology

Ronit Freeman becomes an Associate Editor for the award-winning WIREs (Wiley Interdisciplinary Reviews) series. Each WIREs collection combines some of the most powerful features of encyclopedic reference works and review journals in an innovative online format. Dr. Freeman is excited to take on this new role! Read more here!

Ronit Freeman Featured as speaker for the Biopharmaceutical Manufacturing Interest Group Seminar at NC State

Dr. Ronit Freeman discussed the most recent research discoveries made by the Freeman Lab and how her approach to planning research, which involves detailed stakeholder analysis and market landscape surveys, can quickly benefit everyone through innovative scientific solutions to existing health problems. The Freeman Lab’s most recent research developed the GlycoGrip, a COVID-19 test strip,… Continue reading Ronit Freeman Featured as speaker for the Biopharmaceutical Manufacturing Interest Group Seminar at NC State

Sugar-coated COVID-19 test takes advantage of coronavirus’ sweet tooth

Researchers in the Freeman Lab take advantage of the virus’s sweet tooth by creating a sugar-coated COVID-19 test strip. This test strip has been effective at detecting all known variants of the coronavirus, including delta. They work to determine if the self-test known as GlycoGrip can detect infections caused by the omicron variant too. Read… Continue reading Sugar-coated COVID-19 test takes advantage of coronavirus’ sweet tooth

UNC Innovation Showcase

On Wednesday, April 14th, UNC Chancellor Kevin Guskiewicz, Chapel Hill Mayor Pam Hemminger and other community leaders will kick off a special celebration: the 10-year anniversary of the Innovate Carolina roadmap, which established today’s active network of people and programs that help innovators and ventures make their ideas work. The Freeman Lab will be among the groups… Continue reading UNC Innovation Showcase

Freeman Lab awarded 2 RCSA grants to research COVID-19

The Freeman Lab is happy to announce that we have received funding via two Research Corporation for Science Advancement (RCSA) grants to investigate the COVID-19 virus. The first of these grants, titled “Pan-Covid-19 MultiValent Binders (MVBs) to Block Virus Entry”, was submitted with Rommie Amaro of the University of California and Carlos Simmerling of Stony… Continue reading Freeman Lab awarded 2 RCSA grants to research COVID-19